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Abstract 
Malignant melanoma can metastasize wide-
ly  and  vary  significantly  in  its  histological
appearance; it rarely presents as a deep-seated
mass  without  an  obvious  primary  site  else-
where.  Malignant  peripheral  nerve  sheath
tumor (MPNST) is a high-grade sarcoma char-
acterized by conventional and epithelioid sub-
types.  MPNST  can  demonstrate  heterologous
differentiation, usually in the form of osteosar-
comatous,  chondrosarcomatous,  or  rhabdo-
myosarcomatous differentiation. MPNST does
not  harbor  true  melanocytic  differentiation,
although  epithelioid  MPNST  typically  is  dif-
fusely S-100 protein positive and superficially
can resemble malignant melanoma. An unusu-
al intra-abdominal mass was recently encoun-
tered with features of both melanoma and con-
ventional or epithelioid MPNST containing a
fascicular spindle cell component, an epithe-
lioid component with melanocytic differentia-
tion, as well as a rhabdomyosarcomatous com-
ponent. The terminology “malignant neuroec-
todermal  tumor  with  melanocytic  and  rhab-
domyoblastic  differentiation”  is  proposed  to
describe this neoplasm, reflecting the unusual
concomittant lines of differentiation as well as
offering a possible rationale for nosologically
challenging aspects of this neoplasm.
Introduction
The  neural  crest,  derived  from  embryonic
neuroectoderm, is thought to give rise to sev-
eral cell types within the human body includ-
ing melanocytes and Schwann cells.
1 The pro-
totypic malignant neoplasms arising from or
showing differentiation toward these cell types
are  malignant  melanoma  and  malignant
peripheral  nerve  sheath  tumor  (MPNST),
respectively.  Malignant  melanoma  is  a  rela-
tively common neoplasm arising predominant-
ly  in  the  skin,  but  also  the  eye,  oral  and
anogenital mucosal surfaces, esophagus, and
meninges.  A  small  number  of  metastatic
melanomas present with no clearly identifiable
primary site. Because of its ability to metasta-
size to a wide variety of sites as well as its wide
histological  spectrum,  its  ability  to  mimic
other neoplasms is well recognized. Although
spindle cell melanomas often lose immunore-
activity  for  melanocyte-specific  markers
(HMB-45, Melan-A, tyrosinase, MiTF), they are
virtually all positive for S-100 protein.
2 MPNST
comprises five to ten percent of all soft tissue
sarcomas with a peak incidence in the third to
sixth  decades  of  life.  Approximately  twenty-
five to fifty percent of MPNST are associated
with neurofibromatosis-1.
3,4 MPNST often aris-
es  in  a  pre-existing  neurofibroma  but  can
involve  practically  any  anatomic  site  in  the
body.  In  general,  they  are  considered  to  be
high-grade sarcomas with a high likelihood of
local recurrence and distant metastasis.
The typical conventional MPNST is a fascic-
ular,  spindle  cell  sarcoma  with  variable
immunoreactivity for S-100 protein; it is not
uncommon for conventional MPNST to be only
focally positive for S-100 or lack staining for
the antigen altogether. Of particular interest is
the tendency for MPNST to contain areas with
heterologous  differentiation,  most  commonly
osteosarcomatous,  chondrosarcomatous,  or
rhabdomyosarcomatous  differentiation
(malignant Triton tumor).
4 Epithelioid MPNST
accounts for five percent of all MPNST. In con-
trast to the conventional subtype, these neo-
plasms  have  a  nested  growth  pattern,  an
epithelioid  cytomorphology  with  prominent
nucleoli, as well as strong and diffuse positivi-
ty for S-100 protein; thus bearing a superficial
resemblance  to  melanoma.  Many  epithelioid
MPNST also have a minor spindle cell compo-
nent  which  resembles  conventional  MPNST.
Significantly,  epithelioid  MPNST  is  negative
for melanocyte-specific markers (e.g. HMB-45,
Melan-A, etc.).
4
An  exceptional  intra-abdominal  neoplasm
was recently encountered in consultation with
features of both MPNST and melanoma includ-
ing a fascicular spindle cell component consis-
tent with conventional MPNST, extensive rhab-
domyosarcomatous differentiation, as well as
an  epithelioid  component  reminiscent  of
epithelioid  MPNST  but  showing  melanocytic
differentiation.  Review  of  the  English  lan-
guage  literature  revealed  one  other  similar
case,  a  case  of  an  MPNST  with  divergent
melanocytic and rhabdomyoblastic differentia-
tion.
5
Materials and Methods
This case was received in consultation by
one  of  the  authors  (BPR).  Immunohisto-
chemistry  was  performed  on  formalin-fixed,
paraffin-embedded tissue by the avidin-biotin-
peroxidase complex technique using commer-
cially available antibodies to the following anti-
gens:  S-100  (polyclonal;  1:8000;  DAKO,
Carpinteria, CA, USA), HMB-45/50 (HMB 45/50
cocktail,  1:50/1:250  A.  Gown),  tyrosinase
(T311,  1:100,  Novocastra,  Norwell,  MA),
Melan-A (A103, 1:200, DAKO, Carpinteria, CA,
USA), and microphthalmia transcription factor
(D5, 1:25, R. Schmidt).  
Results
Clinical features
The patient was a 67-year old man who pre-
sented  with  a  large  mass  in  the  abdomen
requiring resection of the spleen, a portion of
the pancreas, as well as a segment of colon and
small  bowel.  Approximately  one  year  subse-
quent to diagnosis of the abdominal mass, the
patient presented with a brain metastasis.
Pathological features
Grossly,  the  intra-abdominal  mass  was  20
cm in greatest dimension. Histologically, it was
characterized by a proliferation of spindle cells
with  enlarged  hyperchromatic  nuclei  with
tapered  ends  and  faintly  eosinophilic  cyto-
plasm  arranged  in  intersecting  fascicles.  A
prominent  herring-bone  pattern  could  be
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observed in several fields (Figure 1A). Other
areas consisted of epithelioid cells with a mod-
erate  amount  of  eosinophilic  cytoplasm  and
enlarged  vesicular  nuclei  with  prominent
nucleoli (Figure 1B). A third pattern was char-
acterized  by  rhabdomyoblasts  containing
abundant eosinophilic cytoplasm with eccen-
trically placed, enlarged nuclei and prominent
nucleoli, representing rhabdomyosarcomatous
heterologous  differentiation  (Figure  1E).
Mitotic activity was brisk throughout the neo-
plasm and tumor necrosis was present.  
S-100 protein was only focally positive in the
fascicles of spindle cells, but strongly and dif-
fusely  positive  in  the  epithelioid  areas
(Figure1C).  Melanocytic  markers  including
HMB-45/50 (Figure 1D), Melan-A, tyrosinase,
and MITF were strongly and diffusely positive
in the epithelioid component but were absent
from  the  spindle  cell  component.  Fontana-
Masson  staining  did  not  demonstrate  any
melanin pigment in either the epithelioid or
spindle cell components. Skeletal muscle dif-
ferentiation was confirmed in the rhabdomy-
oblasts by strong and diffuse immunoreactivity
for desmin (Figure 1F) and myogenin.  
The brain metastasis was characterized by a
morphological  appearance  similar  to  the
epithelioid component of the abdominal mass,
including  epithelioid  cells  with  eosinophilic
cytoplasm,  enlarged  vesicular  nuclei,  and
prominent  nucleoli  (Figure  2A).  The  brain
metastasis was focally positive for S-100 pro-
tein, and variably positive for Melan-A (Figure
2B) and HMB-45. 
Discussion
The chief differential diagnoses in this case
are malignant melanoma and MPNST. One pos-
sibility is that the neoplasm is a melanoma with
a significant spindle cell component and het-
erologous  rhabdomyosarcomatous  differentia-
tion.  Melanocytic  neoplasms  displaying  rhab-
domyosarcomatous  differentiation  have  been
reported in the literature. Four case  reports
have  described  rhabdomyosarcomas  arising
within  congenital  melanocytic  nevi,  demon-
strating that cells with committed melanocytic
differentiation  can  undergo  differentiation
toward a skeletal muscle phenotype.
6-8 There is
also a report of two patients with congenital
melanocytic nevi who subsequently developed
melanomas within their nevi showing areas of
rhabdomyoblastic differentiation.
9 In addition,
the metastasis involving the brain is both clin-
ically  and  pathologically  more  suggestive  of
malignant melanoma than MPNST.
Another possibility is that this tumor repre-
sents an MPNST with a conventional spindle
cell component, heterologous rhabdomyoblas-
tic differentiation, and an epithelioid compo-
nent (reminiscent of epithelioid MPNST) that
happens to show evidence of melanocytic dif-
ferentiation.  This  diagnosis  is  supported  by
the following features. First, deep-seated pri-
mary melanomas (this patient had no other
known primary), though possible, are rare. On
the other hand, MPNST commonly occurs in a
deep-seated location. Furthermore, the spindle
cell component was only focally positive for S-
100 protein and was negative for melanocyte-
Case Report
Figure 1. Abdominal mass. (A) Fascicular spindle cell component; (B) epithelioid compo-
nent with prominent nucleoli; (C) strong and diffuse immunoreactivity for S-100 protein
in the epithelioid component; (D) uniform staining for HMB-45 in the epithelioid com-
ponent; (E) rhabdomyoblasts in areas of rhabdomyosarcomatous heterologous differenti-
ation; (F) strong and diffuse immunoreactivity for desmin in rhabdomyoblasts. 
Figure 2. Metastasis to brain. (A) Epithelioid neoplasm similar in appearance to the pri-
mary neoplasm shown in Figure 1B, (B) immunohistochemistry showing positivity for
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specific markers, which is much more typical
of MPNST than spindle cell melanoma (which
is often strongly positive for S-100 protein, as
mentioned previously). In addition, the phe-
nomenon of rhabdomyoblastic differentiation
is a relatively common occurrence in MPNST,
compared  to  its  case-reportable  status  in
melanoma.  The  feature  of  this  case  that  is
most difficult to reconcile with the diagnosis of
MPNST is the epithelioid component, which
showed  evidence  of  melanocytic  differentia-
tion.  Although  epithelioid  MPNST  can  be
strongly  positive  for  S-100  protein,  melano  -
cyte-specific  markers  such  as  HMB-45  and
Melan-A  should  be  negative.  There  are  rare
cases,  however,  of  MPNST  that  have  been
noted to demonstrate melanocytic differentia-
tion.
10-15
With the difficulties definitively classifying
the neoplasm as either a melanoma or MPNST,
we propose that an alternative term be used:
malignant  neuroectodermal  tumor  with
melanocytic and rhabdomyoblastic differentia-
tion. As alluded to earlier, the term “neuroecto-
dermal tumor” is used to refer to the fact that
both  Schwann  cells  and  melanocytes  are
derived from the neural crest, which in turn is
derived  from  embryonic  neuroectoderm.
1
Neoplasms with features of melanocytic and
schwannian differentiation are not difficult to
find.  Nevi  with  so-called  “neurotization”  of
dermal  nevomelanocytes  are  one  example.
Melanotic  schwannoma  is  a  well-described
entity that occurs sporadically and in the set-
ting  of  Carney’s  complex  (cardiac  and  cuta-
neous  myxomas,  pigmented  nevi,  endocrine
abnormalities, and melanotic schwannomas),
and  can  on  occasion  metastasize  (10-20%).
The neoplastic cells in melanotic schwannoma
can be epithelioid to spindled, and can contain
prominent  nucleoli.  In  addition  to  being
strongly  S-100  protein  positive  and  HMB-45
positive, melanotic schwannomas contain true
melanin pigment, which stains positively with
Fontana-Masson stain. Ultrastructurally, they
are  noted  to  contain  premelanosomes  and
melanosomes.
16 Melanin-containing  neurofi-
bromas have been described also. Fetsch et al.
(2000) characterized a series of 19 pigmented
“melanotic” neurofibromas including diffuse,
plexiform,  diffuse/plexiform  combined,  and
intraneural  epithelioid  morphologies,  which
exhibited immunopositivity for S-100 protein,
HMB-45, Melan-A, and tyrosinase, as well as
melanin  pigment,  confirmed  with  Fontana-
Masson stain.
17Furthermore, melanin-contain-
ing nerve sheath tumors have been described
in a neurofibromatosis rat model (induced by
transplacental  administration  of  ethylnitro-
surea).
18
Because  both  MPNST  and  melanoma  are
thought to arise from or show differentiation
toward neural crest-derived cells, it is not sur-
prising  that  rare  cases  of  melanoma  might
show  rhabdomyoblastic  differentiation  while
rare  cases  of  MPNST  might  demonstrate
melanocytic differentiation. However, as dis-
cussed  previously,  a  rigid  rendering  of  the
diagnosis of either melanoma or MPNST to the
exclusion of the other in this case is not easily
done,  nor  does  it  capture  its  diagnostic
nuances. Instead of forcing this neoplasm into
the  diagnostic  category  of  melanoma  or
MPNST, a more encompassing nomenclature
such  as  malignant  neuroectodermal  tumor
may be appropriate. In the end, cases such as
this help us to re-evaluate our diagnostic crite-
ria  and  highlight  possible  relationships
between different entities.
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